COM(2007)862 EU - Report
Report on current practice with regard to provision of information to patients on medicinal products in accordance with Article 88a of Directive 2001/83/EC, as amended by Directive 2004/27/EC on the EC code relating to medicinal products for human us

Please note

This page contains a limited version of this dossier in the Parlementaire Monitor.

This Communication i is drafted by the Directorate-General Enterprise and Industry (ENTR) i of the European Commission and published on December 20, 2007.

Contents

  1. Key information
  2. Key dates
  3. Related information
  4. Full version
  5. EU Monitor

1.

Key information

official title

Communication from the Commission to the European Parliament and the Council concerning the Report on current practice with regard to provision of information to patients on medicinal products in accordance with Article 88a of Directive 2001/83/EC, as amended by Directive 2004/27/EC on the Community code relating to medicinal products for human us
 
Legal instrument Communication
reference by COM-number i COM(2007)862 EN
Additional COM-numbers SEC(2007)1740
CELEX number i 52007DC0862

2.

Key dates

Document 20-12-2007
Online publication 20-12-2007

3.

Related information

 

4.

Full version

This page is also available in a full version containing the latest state of affairs, the summary of the European Parliament Legislative Observatory, the legal context, other dossiers related to the dossier at hand, the stakeholders involved (e.g. European Commission directorates-general, European Parliament committees, Council configurations and even individual EU Commissioners and Members of the European Parliament) and finally documents of the European Parliament, the Council of Ministers and the European Commission.

The full version is available for registered users of the EU Monitor by ANP and PDC Informatie Architectuur.

5.

EU Monitor

The EU Monitor enables its users to keep track of the European process of lawmaking, focusing on the relevant dossiers. It automatically signals developments in your chosen topics of interest. Apologies to unregistered users, we can no longer add new users.This service will discontinue in the near future.